Keyphrases
Gastric Bypass Surgery
100%
Epigallocatechin-3-gallate
93%
Weight Loss
90%
Zellweger Spectrum Disorder
83%
Intestinal Tumorigenesis
70%
ApcMin Mouse
68%
Incretin
45%
Catechin
40%
Gastric Bypass
39%
Human Colon Cancer Cells
35%
Green Tea Polyphenols
33%
Obesity
33%
Type 2 Diabetic Patients
33%
Intake Methods
33%
Metabolic Syndrome
29%
Green Tea
29%
Oral Glucose
27%
Family Caregivers
27%
Type 2 Diabetes Mellitus (T2DM)
25%
Equivalent Weight
24%
Small Intestine
23%
Glucagon-like
23%
Arachidonic Acid Metabolism
22%
Peroxisome Biogenesis
22%
Caregivers
21%
High-fat Diet
21%
Peptide YY3-36
20%
Intestinal Cancer
20%
Glucose Control
20%
Caloric Restriction
20%
Tumorigenesis
19%
Remission
19%
Dose Effect
18%
Metabolic Disease
18%
Peroxisomal Disorders
18%
Metabolic Impact
18%
Community-engaged
18%
Rare Diseases
18%
Min Mice
18%
Wheat Bran Oil
16%
Cancer Cell Growth
16%
Polyphenon E
16%
Convergent Mixed Methods
16%
Emotional Experience
16%
Quality of Life Survey
16%
Rare Disorders
16%
Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
16%
GABA Metabolism
16%
Clinical Treatment
16%
Symptom Prevalence
16%
Medicine and Dentistry
Gastric Bypass Surgery
100%
Spectrum Disorder
66%
Incretin
44%
Diseases
35%
Metabolic Syndrome
33%
Prevalence
33%
Patient with Type 2 Diabetes
33%
Maturity Onset Diabetes of the Young
28%
Peroxisome
22%
Biogenesis
22%
Rare Disease
21%
Diabetic Obesity
20%
Caloric Restriction
20%
Cross Sectional Study
19%
Peptide YY [3-36]
19%
Gastric Bypass
18%
Polyphenol
16%
Carcinogenesis
16%
Epigallocatechin Gallate
16%
Immigrant
16%
Oxyntomodulin
16%
Orphan Disorder
16%
Succinic Semialdehyde Dehydrogenase Deficiency
16%
4 Aminobutyric Acid Metabolism
16%
Chronic Disease
16%
Diet Therapy
16%
Calcium Intake
16%
Milk Allergy
16%
Dipeptidyl Peptidase IV
16%
Fatty Liver
16%
Isotopes of Calcium
16%
Quality of Life
16%
Meta-Analysis
16%
Clinical Finding
16%
Dextran Sulfate
16%
Azoxymethane
16%
Disease
16%
Rhizomelic Chondrodysplasia Punctata
16%
High Fat Food
16%
Diabetes
15%
Nutrient Intake
14%
Glucagon Like Peptide 1
13%
Genetic Disorder
11%
Insulin Release
10%
Ghrelin
10%
Clinical Trial
8%
Glucose Homeostasis
8%
Proinsulin
7%
Gastric Inhibitory Polypeptide
7%
Lifespan
7%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
69%
Epigallocatechin Gallate
58%
Catechin
43%
Colon Carcinoma
41%
Non Insulin Dependent Diabetes Mellitus
36%
Incretin
35%
Diseases
33%
Malignant Neoplasm
26%
Intestine Cancer
22%
Remission
21%
Arachidonic Acid
20%
Polyphenon E
16%
Polyphenol
16%
Arachidonate 5 Lipoxygenase
16%
Prostaglandin Synthase
16%
Diketone
16%
Curcumin
16%
Cytosolic Phospholipase A2
16%
Cancer Growth
16%
Oxyntomodulin
16%
Bioavailability
16%
Genistein
16%
Azoxymethane
16%
Dextran Sulfate
16%
Mouse Model
15%
CF-1 Mouse
13%
Glucagon-Like Peptide-1
12%
Intestine Tumor
10%
Phytochemical
10%
Camellia Sinensis
9%
Cyclooxygenase 2
9%
Theaceae
8%
Catenin
7%
Neoplasm
7%
Uvomorulin
7%
Lipopolysaccharide
7%
Prostaglandin E2
7%
Phytosterol
6%
Somatomedin C
6%
Beta Catenin
6%
Gastrointestinal Hormone
6%
Genetic Disorder
6%
Amylin
5%
Gastric Inhibitory Polypeptide
5%
Proinsulin
5%
Treatment Group
5%
